Diabetes Care Devices - Saudi Arabia

Revenue in the Diabetes Care Devices market market in Saudi Arabia is anticipated to reach US$193.40m in 2024.
Furthermore, this revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 11.54%, leading to a market volume of US$334.00m by 2029.
In the context of global comparisons, the majority of revenue is expected to be generated the United States, which is projected to reach US$11.71bn in 2024.
In Saudi Arabia, the growing prevalence of diabetes is driving an increased demand for innovative diabetes care devices, reflecting a shift toward advanced healthcare solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Saudi Arabia is witnessing considerable growth, fueled by increasing diabetes prevalence, enhanced awareness of disease management, and advancements in technology, which offer more effective monitoring and treatment options for patients.

Customer preferences: In Saudi Arabia, there is a growing preference for integrated diabetes care solutions that combine technology with personalized health management. Consumers are increasingly opting for smart glucose monitoring devices that offer real-time data sharing with healthcare providers, reflecting a desire for collaborative care. Additionally, the rising trend of health consciousness among younger demographics is driving interest in mobile health applications that facilitate lifestyle management and dietary tracking. This shift is further supported by cultural emphasis on preventative healthcare, aligning with national health initiatives.

Trends in the market: In Saudi Arabia, the Diabetes Care Devices Market is experiencing a surge in demand for connected health technologies, with a focus on smart insulin delivery systems and continuous glucose monitors (CGMs) that sync with mobile applications. The trend towards personalized diabetes management is being fueled by an increasing awareness of the importance of lifestyle modifications and data-driven health decisions. This shift not only enhances patient engagement but also encourages collaboration between patients and healthcare providers. As a result, industry stakeholders are urged to innovate and invest in integrated solutions that align with the national vision for improved health outcomes.

Local special circumstances: In Saudi Arabia, the Diabetes Care Devices Market is uniquely influenced by cultural factors such as the prevalence of diabetes in the population, which is exacerbated by dietary habits and sedentary lifestyles. The government's Vision 2030 initiative emphasizes health awareness, driving investments in advanced diabetes management technologies. Additionally, local regulations support the adoption of telemedicine and digital health solutions, fostering collaboration between patients and healthcare providers. This combination of cultural awareness and supportive policies creates a conducive environment for innovative diabetes care devices that resonate with the needs of the population.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Saudi Arabia is significantly influenced by macroeconomic factors such as national economic stability, healthcare expenditure, and global economic trends. The Kingdom's commitment to diversify its economy under Vision 2030 has led to increased investment in healthcare infrastructure, enhancing access to advanced diabetes management technologies. Additionally, rising healthcare costs and a growing aging population necessitate innovative solutions, driving market demand. Global trends in technology adoption and collaborative healthcare practices further accelerate the integration of diabetes care devices within the healthcare system, ensuring they meet the population's evolving needs.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.